Active Ingredient: RIFAMPIN
Proprietary Name: RIFAMPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 600MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A064217
Product Number: 001
Approval Date: Oct 29, 1999
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information